Cytokeratin 14 (CK14) is a low molecular weight acidic keratin that is one of the cytoskeletal proteins mainly present in stratified squamous epithelial cells. It has various functions such as maintaining morphology, regulating proliferation, and mediating migration. In clinical practice, CK14 is mainly used as a diagnostic biomarker for squamous cell carcinoma, and it is lowly expressed in adenocarcinoma, which makes it useful for assisting in identification. Moreover, the expression level of CK14 in lung squamous cell carcinoma is positively correlated with tumor invasiveness, speculated that its high expression may stimulate the proliferation and migration of cancer cells. However, some scholars pointed out that CK14 is down-regulated with increased severity of esophageal squamous cell carcinoma and cervical squamous cell carcinoma increases, and its low expression is considered as a pathological feature of malignant transformation of epithelial cells. In addition, the positive rate of CK14 in triple negative breast cancer is significantly increased, which is closely related to the occurrence and development of tumors, which may be because CK14 forms cytoskeleton in cancer cells that can lead to tumor infiltration.
Cytokeratin 14
Product features
Sensitivity
Specificity
Multi-platform
Stability
Specifications
- Catalog No.
- MY134
- Clone
- MyM1-CK14
- Host species
- Mouse
- Isotype
- -
- Light chain type
- -
- Specifications
- Working solution: 3mL/6mL, Concentrated solution: 0.2mL/1mL
- Validated applications
- -
- Validated application procedures
- -
- Reactivity
- Human tissue; other species not tested
- Platform
- Basic Platform, Myab Platform
- Recommended dilution
- 1:100
- Concentration
- 1:100
Product images
[1] Chu PG1, Lyda MH, Weiss LM., et al. Cytokeratin 14 expression in epithelial neoplasms: a survey of 435 cases with emphasis on its value in differentiating squamous cell carcinomas from other epithelial tumours. Histopathology. 2001 Jul;39(1):9-16.
[2] Chu PG1, Weiss LM et al.. Cytokeratin 14 immunoreactivity distinguishes oncocytic tumour from its renal mimics: an immunohistochemical study of 63 cases.. Histopathology. 2001 Nov;39(5):455-62.
[2] Chu PG1, Weiss LM et al.. Cytokeratin 14 immunoreactivity distinguishes oncocytic tumour from its renal mimics: an immunohistochemical study of 63 cases.. Histopathology. 2001 Nov;39(5):455-62.
- Validated
- Not recommended
- Not tested
| Myab | Roche BenchMark GX Ultraview | Roche BenchMark GX Optiview | Roche BenchMark ULTRA Ultraview | Roche BenchMark ULTRA Optiview | Leica Bond Max | Dako Autostainer Link 48 | Quaero | |
|---|---|---|---|---|---|---|---|---|
| Equipment | ||||||||
| Test status | ||||||||
| Dilution ratio | ||||||||
| Test parameters |
- Form
- Liquid
- Purification
- Affinity chromatography
- Storage temperature
- 4°C
- Shelf life
- 3 years
- Storage solution
- 0.05 mol/L Tris-HCl (pH 7.2), 0.015 mol/L sodium azide, and protein stabilizer.
- Shipping
- 2–8°C refrigerated shipping in insulated box with cold packs